Company: CRL
Filing Date: 2025-11-05
Form Type: 10-Q
Source: 0001100682-25-000043
Chunk: 35

Company: CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Filing Date: 2025-11-05
Form: 10-Q
Item: Item 2
Chunk 35
---
 51.1 %Effective tax rate36.3 %23.0 %1,330 bps

Income tax expense for the three months ended September 27, 2025 was $31.6 million, an increase of $10.7 million compared to $20.9 million for the corresponding period in 2024. Our effective tax rate was 36.3% for the three months ended September 27, 2025 compared to 23.0% for the corresponding period in 2024. The increase in our effective tax rate in the three months ended September 27, 2025 compared to the corresponding period in 2024 was primarily attributable to an increase in net U.S. taxation of foreign operations, as well as the current and deferred impact of tax legislation enacted in the third quarter of fiscal 2025 in a foreign jurisdiction.

31 

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Nine Months Ended September 27, 2025 Compared to Nine Months Ended September 28, 2024

Revenue and Operating Income

The following tables present consolidated revenue by type and by reportable segment:

Nine Months EndedSeptember 27, 2025September 28, 2024$ change% change(in thousands, except percentages)Service revenue$2,446,801 $2,492,225 $(45,424)(1.8)%Product revenue574,354 555,215 19,139 3.4 %Total revenue$3,021,155 $3,047,440 $(26,285)(0.9)%

Nine Months EndedSeptember 27, 2025September 28, 2024$ change% changeImpact of FX(in thousands, except percentages)RMS$639,818 $625,120 $14,698 2.4 %0.5 %DSA1,811,323 1,847,931 (36,608)(2.0)%0.5 %Manufacturing570,014 574,389 (4,375)(0.8)%0.7 %Total revenue$3,021,155 $3,047,440 $(26,285)(0.9)%0.5 %

The following table presents operating income by reportable segment:

Nine Months EndedSeptember 27, 2025September 28, 2024$ change% changeImpact of FX(in thousands, except percentages)